Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Tetracycline-spironolactone formulation; a team play

  • At: 2008 FIP Congress in Basel (Switzerland)
  • Type: Poster
  • By: SER, Filip (City Departement for Skin and Veneral Dieases, Belgrade, Yugoslavia)
  • Co-author(s): Petronijevic, Dragoslav (PHARMACY BELGRADE, BELGRADE, Serbia)
    Gajdas, Mirjana (PHARMACY BELGRADE, BELGRADE, Serbia)
    Stojsic, Radmila (PHARMACY BELGRADE, BELGRADE, Serbia)
    Muzdeka, Nada (PHARMACY BELGRADE, BELGRADE, Serbia)
    Sarenac, Svetlana (PHARMACY BELGRADE, BELGRADE, Serbia)
  • Abstract:

    Spironolactone was originally developed in the early 1970's as a competitive antagonist of aldosterone for the treatment of hyperaldosteronism, edema and hypokalemia. Topical spironolactone can act as an anti-androgen in human sebaceous glands, competing with dihydrotestosterone - DHT receptors and producing a decrease of labeled DHT. Applied..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses